INSM Stock Analysis: Buy, Sell, or Hold?
INSM - Insmed, Inc.
$145.30
-2.30 (-1.56%)
▼
5d:
+6.84%
30d:
-3.13%
90d:
-17.61%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
INSM is down 7.0% this week, but smart money is accumulating calls. Top strike: $165 2026-04-17 with 2,222 OI. Call ratio: 93% View Scanner →
Strength: 7.8/10
Get Alerted When INSM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INSM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: INSM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.61
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$7.83
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INSM is currently trading at $145.30, which is considered fair relative to its 30-day fair value range of $140.12 to $153.74. The stock's valuation (Forward PE: 403.6) is in line with its historical norms (374.6). At these levels, the market is pricing in 2.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INSM is in a strong downtrend. Immediate support is located at $135.73, while resistance sits at $149.88.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $213.16 (+46.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INSM is in a strong downtrend. Immediate support is located at $135.73, while resistance sits at $149.88.
Market Sentiment: INSM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $213.16 (+46.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$140.12 -
$153.74
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.7% below Wall St target ($213.16)
- NEUTRAL: Market pricing in 2.5% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$140.12 -
$153.74
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$135.73
Resistance Level
$149.88
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
403.61
Wall Street Target
$213.16
(+46.7%)
Revenue Growth (YoY)
152.6%
Profit Margin
-210.5%
Valuation Premium vs History
+2.5% premium
PE vs Historical
403.6 vs 374.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.5%
(market-implied from PE analysis)
1-Year Target
$148.93
(+3%)
2-Year Target
$152.66
(+5%)
3-Year Target
$156.47
(+8%)
3-Yr Target (if PE normalizes)
(PE: 404→375)
PE COMPRESSION
$145.23
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: March 30, 2026 8:56 AM ET
Data refreshes hourly during market hours. Next update: 9:56 AM
Data refreshes hourly during market hours. Next update: 9:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
William Lewis
SELL
10699 shares
2026-03-05
William Lewis
SELL
10699 shares
2026-02-19
William Lewis
SELL
13396 shares
2026-02-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 65 BUY |
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 54 HOLD |
Advanced INSM Option Strategies
Professional options setups generated by AI based on today's INSM price and gamma walls.
